Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover

Carsten Denkert, Jan Budczies, Wilko Weichert, Gert Wohlgemuth, Martin Scholz, Tobias Kind, Silvia Niesporek, Aurelia Noske, Anna Buckendahl, Manfred Dietel, Oliver FiehnMolecular 2008 · DOI

Abstract

This study demonstrates that metabolic profiling facilitates biochemical phenotyping of normal and neoplastic colon tissue at high significance levels and points to GC-TOF-based metabolomics as a new method for molecular pathology investigations.

Introduction

While the genetic mutations driving colorectal cancer (CRC) are well-documented, the actual metabolic "output" of these mutations—the metabolites that fuel and sustain a tumor—remains less understood. Most cancer research focuses on genomics or proteomics. However, the metabolome represents the final downstream product of gene expression and environmental factors. Understanding these chemical shifts is crucial because metabolic deregulation is a hallmark of cancer. This study aims to determine if metabolic profiling can reliably distinguish between normal and neoplastic tissue and to identify which specific biochemical pathways are hijacked by the disease.

Methods

The research team utilized Gas Chromatography Time-of-Flight Mass Spectrometry (GC-TOF-MS), a high-sensitivity technique capable of detecting hundreds of low-molecular-weight compounds simultaneously.

GC-TOF-MS chromatograms

The methodology included:

  • Unsupervised Analysis: Principal Component Analysis (PCA) was applied to determine if samples would naturally group into "cancer" vs. "normal" without prior labeling.
  • Supervised Analysis: Welch’s t-tests with Bonferroni corrections identified specific metabolites of interest.
  • The "PROFILE" Approach: This novel bioinformatic method mapped metabolites onto the KEGG interaction lattice, calculating "biochemical distance" to visualize functional changes in the tumor.

The study analyzed 45 human colon samples (27 primary carcinomas and 18 normal mucosa samples), including 15 paired cases to control for individual variability.

Results

Robust Metabolic Signatures

The metabolic difference between tumor and healthy tissue is profound. PCA separated the two groups with nearly 100% accuracy, demonstrating that the metabolic signature of cancer is highly distinct despite biological noise.

PCA separation of tissue types

Pathway Deregulation

The study successfully detected 206 metabolites, with 82 showing significant differences (p < 0.01).

  • TCA Cycle and Lipids: Intermediates like citrate and succinate were generally lower in cancer tissues, suggesting a diversion of carbon sources away from energy production toward cellular building blocks.
  • Amino Acid Turnover: Almost all amino acids were significantly elevated in tumors, indicating increased uptake or synthesis to support rapid growth. Beta-alanine showed the most significant increase (nearly 5-fold).
  • Nucleotide Synthesis: Upregulation was observed in urea cycle metabolites, purines, and pyrimidines.

Discussion and Conclusion

The researchers achieved ~95% sensitivity and specificity in predicting cancerous tissue using metabolic profiles. While the study identifies significant chemical shifts, the exact enzymatic causes (e.g., for the beta-alanine spike) require further validation. Future work should focus on larger cohorts to validate these metabolites as clinical biomarkers for staging and prognosis, potentially integrating metabolomics into routine molecular pathology to predict treatment responses.

Summary updated

Abstract

This study demonstrates that metabolic profiling facilitates biochemical phenotyping of normal and neoplastic colon tissue at high significance levels and points to GC-TOF-based metabolomics as a new method for molecular pathology investigations.
BibTeX
@inproceedings{denkert2008metabolite,
  author = {Carsten Denkert and Jan Budczies and Wilko Weichert and Gert Wohlgemuth and Martin Scholz and Tobias Kind and Silvia Niesporek and Aurelia Noske and Anna Buckendahl and Manfred Dietel and Oliver Fiehn},
  title = {{Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover}},
  booktitle = {Molecular},
  year = {2008},
  doi = {10.1186/1476-4598-7-72},
}
Figure